Literature DB >> 31471094

[Thyroid tumors in the adult revealed by unilateral laryngeal paralysis].

Lauranne Alciato1, François Rubin2, Alexandre Villeneuve1, Candice La Croix1, Pierre Bonfils1, Ollivier Laccourreye3.   

Abstract

GOAL: To analyze the characteristic of thyroid tumor associated with ipsilateral unilateral laryngeal paralysis (ULP) in the adult patient.
MATERIALS AND METHODS: Retrospective analysis of a cohort of 30 patients with ULP related to an ipsilateral thyroid tumor (group A) and comparison with a cohort of 99 patients in whom ULP revealed a non-thyroid tumor (group B).
RESULTS: Group A consisted of 66.6% of women with a mean age of 69 years. Comparison between both groups noted that female gender was more frequent in group A (66.6% vs. 17.1%, P<0.0001), and the underlying tumor was more frequently malignant in group B (89.9% vs. 43.4%, P<0.0001). Within group A, the incidence for recovery of laryngeal motion varied form 0% for malignant tumor to 50% for benign tumor. In patients with a benign thyroid tumor in whom recovery of laryngeal motion did not occur, the watch policy initiated allowed to detect a pathology (malignant tumor or neurological) explaining persistent ULP in 57% of cases.
CONCLUSION: The present series confirm that ULP in the face of thyroid tumor does not allow to distinguish formally between benign and malignant tumors and highlight the value of a long term watch policy in patients with benign thyroid tumor pathology in whom recovery of laryngeal mobility does not occur.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31471094     DOI: 10.1016/j.lpm.2019.07.036

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

Review 1.  Thyroidectomy-related Swallowing Difficulties: Review of the Literature.

Authors:  Ana Đanić-Hadžibegović; Filip Hergešić; Ema Babić; Juraj Slipac; Ratko Prstačić
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.